8 research outputs found
The Shaggy Aorta Syndrome: an updated review
Shaggy aorta (SA) depicts the severe aortic surface degeneration, extremely friable and likely to cause spontaneous peripheral and visceral embolization or during catheterization, aortic manipulation, surgery or minimally invasive procedures. This study aims to provide the most accurate and up-to-date information on this disease
Transcatheter arterial embolization (tae) of canccer-related bleerdibng
Background and Objectives: Roughly 10% of cancer patients experience an episode of bleeding.
The bleeding severity can range from occasional trivial bleeds to major bleeding. The treatment for the
bleeding may vary, depending on the clinical condition and anatomical site, and may include various
strategies, among which TAE is a cornerstone of major bleeding management. However, the existing
literature on tumor hemorrhages is inconsistent. The objective of this multicenter retrospective cohort
study was to evaluate the effectiveness and safety of arterial embolization in the treatment of tumor
hemorrhages in patients with solid cancers. Materials and Methods: The data for patients with solid
cancers undergoing TAE for the management of tumor hemorrhages from January 2020 to May 2023
were gathered. Results: A total of 92 patients with cancer-related bleeding were treated between
January 2020 and May 2023. No bleeding was detected by X-ray angiography (XA) in 12 (13%) cases;
therefore, a blind embolization was performed. The most common bleeding site was the liver (21.7%).
A total of 66 tumor hemorrhages were spontaneous. The most commonly used embolic agent was
polyvinyl alcohol (PVA) particles (30.4%). Technical success was achieved in 82 (89.1%) cases, with an
84.8% clinical success rate related to 14 cases of rebleeding. Proximal embolization was performed for
19 (20.7%) patients. Complications were recorded for 10 (10.9%) patients. The 30-day bleeding-related
mortality was 15.2%. The technical success, clinical success, proximal embolization rate, and 30-day
rebleeding were worse in the subset of patients undergoing TAE with coils. Conclusions: Transcatheter
arterial embolization (TAE) represents a viable and potentially life-saving therapeutic approach in
the management of tumor hemorrhages, demonstrating a notable effectiveness and safety. The TAE of bleeding tumors using coils resulted in a higher rate of non-superselective proximal embolization,
with a trend toward lower clinical success rates and higher rebleeding episodes